Pulmonary gas exchange in relation to exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.

IF 16.6 1区 医学 Q1 RESPIRATORY SYSTEM European Respiratory Journal Pub Date : 2024-11-07 DOI:10.1183/13993003.00722-2024
Bryce N Balmain, Andrew R Tomlinson, Josh T Goh, James P MacNamara, Denis J Wakeham, Tiffany L Brazile, Michael G Leahy, Kevin C Lutz, Linda S Hynan, Benjamin D Levine, Satyam Sarma, Tony G Babb
{"title":"Pulmonary gas exchange in relation to exercise pulmonary hypertension in patients with heart failure with preserved ejection fraction.","authors":"Bryce N Balmain, Andrew R Tomlinson, Josh T Goh, James P MacNamara, Denis J Wakeham, Tiffany L Brazile, Michael G Leahy, Kevin C Lutz, Linda S Hynan, Benjamin D Levine, Satyam Sarma, Tony G Babb","doi":"10.1183/13993003.00722-2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Exercise pulmonary hypertension (ePH), defined as a mean pulmonary artery pressure (mPAP)/cardiac output (Qc) slope >3 WU during exercise, is common in patients with heart failure with preserved ejection fraction (HFpEF). However, the pulmonary gas exchange-related effects of an exaggerated ePH (EePH) response are not well-defined, especially in relation to dyspnea on exertion (DOE) and exercise intolerance.</p><p><strong>Methods: </strong>48 HFpEF patients underwent invasive (pulmonary and radial artery catheters) constant-load (20W) and maximal incremental cycle testing. Hemodynamic measurements (mPAP and Qc), arterial blood and expired gases, and ratings of breathlessness (RPB, Borg 0-10) were obtained. The mPAP/Qc slope was calculated from rest-to-20W. Those with a mPAP/Qc slope >4.2 (median) were classified as HFpEF+EePH (n=24) and those with a mPAP/Qc slope <4.2 were classified as HFpEF (without EePH) (n=24). The A-aDO<sub>2</sub>, V<sub>D</sub>/V<sub>T</sub> (Bohr equation), and the V<sub>E</sub>/VCO<sub>2</sub> slope (from rest-to-20W) were calculated.</p><p><strong>Results: </strong>PaO<sub>2</sub> was lower (p=0.03), and V<sub>D</sub>/V<sub>T</sub> was higher (p=0.03) at peak exercise in HFpEF+EePH compared with HFpEF. A-aDO<sub>2</sub> was similar at peak exercise between groups (p=0.14); however, HFpEF+EePH achieved the peak A-aDO<sub>2</sub> at a lower peak work rate (p<0.01). The V<sub>E</sub>/VCO<sub>2</sub> slope was higher in HFpEF+EePH compared with HFpEF (p=0.01). RPB was ≥1-unit higher at 20W and VO<sub>2peak</sub> was lower (p<0.01) in HFpEF+EePH compared with HFpEF.</p><p><strong>Conclusions: </strong>These data suggest that EePH contributes to pulmonary gas exchange impairments during exercise by causing a V/Q mismatch that provokes both ventilatory inefficiency and hypoxemia, both of which seem to contribute to DOE and exercise intolerance in patients with HFpEF.</p>","PeriodicalId":12265,"journal":{"name":"European Respiratory Journal","volume":" ","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Respiratory Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.00722-2024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Exercise pulmonary hypertension (ePH), defined as a mean pulmonary artery pressure (mPAP)/cardiac output (Qc) slope >3 WU during exercise, is common in patients with heart failure with preserved ejection fraction (HFpEF). However, the pulmonary gas exchange-related effects of an exaggerated ePH (EePH) response are not well-defined, especially in relation to dyspnea on exertion (DOE) and exercise intolerance.

Methods: 48 HFpEF patients underwent invasive (pulmonary and radial artery catheters) constant-load (20W) and maximal incremental cycle testing. Hemodynamic measurements (mPAP and Qc), arterial blood and expired gases, and ratings of breathlessness (RPB, Borg 0-10) were obtained. The mPAP/Qc slope was calculated from rest-to-20W. Those with a mPAP/Qc slope >4.2 (median) were classified as HFpEF+EePH (n=24) and those with a mPAP/Qc slope <4.2 were classified as HFpEF (without EePH) (n=24). The A-aDO2, VD/VT (Bohr equation), and the VE/VCO2 slope (from rest-to-20W) were calculated.

Results: PaO2 was lower (p=0.03), and VD/VT was higher (p=0.03) at peak exercise in HFpEF+EePH compared with HFpEF. A-aDO2 was similar at peak exercise between groups (p=0.14); however, HFpEF+EePH achieved the peak A-aDO2 at a lower peak work rate (p<0.01). The VE/VCO2 slope was higher in HFpEF+EePH compared with HFpEF (p=0.01). RPB was ≥1-unit higher at 20W and VO2peak was lower (p<0.01) in HFpEF+EePH compared with HFpEF.

Conclusions: These data suggest that EePH contributes to pulmonary gas exchange impairments during exercise by causing a V/Q mismatch that provokes both ventilatory inefficiency and hypoxemia, both of which seem to contribute to DOE and exercise intolerance in patients with HFpEF.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
射血分数保留型心力衰竭患者肺气体交换与运动性肺动脉高压的关系。
背景:运动性肺动脉高压(ePH)是指运动时平均肺动脉压(mPAP)/心输出量(Qc)斜率>3 WU,常见于射血分数保留型心力衰竭(HFpEF)患者。方法:48 名 HFpEF 患者接受了有创(肺动脉和桡动脉导管)恒定负荷(20W)和最大增量循环测试。方法:48 名高频低氧血症患者接受了有创(肺动脉和桡动脉导管)恒定负荷(20W)和最大增量循环测试,并获得了血流动力学测量值(mPAP 和 Qc)、动脉血气和呼出气体以及呼吸困难评分(RPB,Borg 0-10)。mPAP/Qc 斜率是从静息到 20W 的计算值。mPAP/Qc斜率大于4.2(中位数)者被归类为HFpEF+EePH(n=24),mPAP/Qc斜率为2者被归类为HFpEF+EePH(n=24),VD/VT(玻尔方程)和VE/VCO2斜率(从静息到20W)被计算出来:结果:与 HFpEF 相比,HFpEF+EePH 在运动高峰时的 PaO2 更低(p=0.03),VD/VT 更高(p=0.03)。各组间在运动峰值时的 A-aDO2 相似(p=0.14);然而,HFpEF+EePH 以较低的峰值工作率达到 A-aDO2 峰值(与 HFpEF 相比,HFpEF+EePH 的 pE/VCO2 斜率更高(p=0.01))。在 20W 时,RPB 高出≥1 个单位,VO2 峰值较低(p结论:这些数据表明,EePH 会导致 V/Q 失配,引发通气效率低下和低氧血症,从而造成运动时肺部气体交换障碍,而这两种情况似乎都会导致 HFpEF 患者出现 DOE 和运动不耐受。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Respiratory Journal
European Respiratory Journal 医学-呼吸系统
CiteScore
27.50
自引率
3.30%
发文量
345
审稿时长
2-4 weeks
期刊介绍: The European Respiratory Journal (ERJ) is the flagship journal of the European Respiratory Society. It has a current impact factor of 24.9. The journal covers various aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine, and thoracic surgery. In addition to original research material, the ERJ publishes editorial commentaries, reviews, short research letters, and correspondence to the editor. The articles are published continuously and collected into 12 monthly issues in two volumes per year.
期刊最新文献
European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis. Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA. Determination of loss of chromosome Y in peripheral blood cells in males with idiopathic pulmonary fibrosis. ERJ advances: epigenetic ageing and leveraging DNA methylation in chronic respiratory diseases. Perspective on WHO implementation guidance on TB infection prevention and control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1